Adicet Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adicet Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Adicet Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $111M.
  • Adicet Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $236K, a 99.4% decline from 2022.
  • Adicet Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $41.5M, a 82.9% decline from 2021.
  • Adicet Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $243M, a 79994% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $236K -$41.3M -99.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $41.5M -$201M -82.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $243M +$242M +79994% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $303K -$76.6M -99.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $76.9M +$65.9M +597% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $11M -$53.3M -82.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $64.4M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.